Two Important Criteria for Reducing the Risk of Postoperative Ulcers at the Gastrojejunostomy Site after Gastric Bypass: Patient Compliance and Type of Gastric Bypass

Scheffel, Oliver; Daskalakis, Markos; Weiner, Rudolf A.

doi:10.1159/000327340

Cited by 14 publications

(8 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, several studies have indicated the potential influence of nonsteroidal anti-inflammatory drugs (NSAIDs), after bariatric surgery on marginal ulcers formation. Scheffel et al (2011) identified 54 marginal ulcer patients who underwent bariatric surgery from 2006 to 2010 and they found that 75% of the 54 patients (p < .0001) had consumed NSAIDs, alcohol, or nicotine. Wilson et al (2006) suggested that NSAID use increased the risk of marginal ulcers following surgery (Adjusted OR=11.5, 95% CI: 4.8–28).…”

Section: Resultsmentioning

confidence: 99%

Substance use after bariatric surgery: A review

2016

Journal of Psychiatric Research

View full text Add to dashboard Cite

Background Prevalence of obesity has increased dramatically. Obese individuals may undergo bariatric surgery to lose excessive body fat and mitigate obesity-related comorbidities. However, bariatric patients are particularly vulnerable to substance use problems. We conducted a review to examine the prevalence change and factors associated with substance use and determine the association between substance use and health status after weight loss among bariatric patients. Methods We searched peer-reviewed articles published between January 1990 and January 2015 in several databases (PubMed, PsycINFO, Cochrane Library, Google Scholar) using different keywords combinations. Studies that focused on pre-surgery substance use only or without reported effect measurements were excluded. Results Overall, 40 studies were included in the review. Preoperative history of substance use was a reliable correlate of postoperative substance use. The prevalence of postoperative alcohol use was higher among patients with preoperative history of alcohol use than those without. Postoperative prevalence of alcohol use ranged from 7.6% to 11.8%. No significant prevalence change in cigarette smoking from pre- to postoperative period was observed. Time effect was not observed on smoking or drug use prevalence, while an increase in alcohol consumption was inconsistent across studies. The proportion of new-onset substance users among bariatric patients after surgery ranged from 34.3% to 89.5%. Conclusion Substance use is associated with poor health among bariatric patients. Preoperative assessment and postoperative follow-up should include interventions to reduce relapse among users and prevent substance use initiation.

show abstract

Section: Resultsmentioning

confidence: 99%

Substance use after bariatric surgery: A review

2016

Journal of Psychiatric Research

View full text Add to dashboard Cite

show abstract

“…Alcohol, as well as smoking and vaping of nicotine and nonsteroidal antiinflammatory drug use, are significant risk factors for ulcer formation after RYGB, accounting for 75% of ulcers found 1 study [137]. Adolescents with obesity were more likely to use both cigarettes and e-cigarettes than their normal weight peers [138].…”

Section: Obesity Disease-related Co-morbidities and Outcomesmentioning

confidence: 99%

ASMBS pediatric metabolic and bariatric surgery guidelines, 2018

Pratt

Browne

Browne³

et al. 2018

Surgery for Obesity and Related Diseases

412

285

View full text Add to dashboard Cite

The American Society for Metabolic and Bariatric Surgery Pediatric Committee updated their evidence-based guidelines published in 2012, performing a comprehensive literature search (2009-2017) with 1387 articles and other supporting evidence through February 2018. The significant increase in data supporting the use of metabolic and bariatric surgery (MBS) in adolescents since 2012 strengthens these guidelines from prior reports. Obesity is recognized as a disease; treatment of severe obesity requires a life-long multidisciplinary approach with combinations of lifestyle changes, nutrition, medications, and MBS. We recommend using modern definitions of severe obesity in children with the Centers for Disease Control and Prevention age- and sex-matched growth charts defining class II obesity as 120% of the 95th percentile and class III obesity as 140% of the 95th percentile. Adolescents with class II obesity and a co-morbidity (listed in the guidelines), or with class III obesity should be considered for MBS. Adolescents with cognitive disabilities, a history of mental illness or eating disorders that are treated, immature bone growth, or low Tanner stage should not be denied treatment. MBS is safe and effective in adolescents; given the higher risk of adult obesity that develops in childhood, MBS should not be withheld from adolescents when severe co-morbidities, such as depressed health-related quality of life score, type 2 diabetes, obstructive sleep apnea, and nonalcoholic steatohepatitis exist. Early intervention can reduce the risk of persistent obesity as well as end organ damage from long standing co-morbidities.

show abstract

“…However, patients schedule to undergo sleeve gastrectomy are presumed to have no significant gastric pathology. Even so, eradication should decrease the risk of gastro-duodenal peptic lesions in the gastro-jejunostomy site after gastric bypass ( 17 ). Laparoscopic sleeve gastrectomy has been advocated as a multipurpose restrictive procedure for obese patients ( 18 ) with low incidence of complications ( 19 ).…”

Section: Discussionmentioning

confidence: 99%

Chronic Gastritis in Morbidly Obese Patients with Sleeve Gastrectomy

Makki¹,

Aldaqal²,

Alorabi³

et al. 2016

Electron physician

View full text Add to dashboard Cite

IntroductionObesity is a condition that has significant impact on public health. Recent exciting studies have linked chronic gastritis and H. pylori infection to obesity. Chronic gastritis has shown increased prevalence in obesity, more particularly H. pylori-related gastritis. This study aimed to determine the prevalence of chronic gastritis in morbidly obese patients who were subjected to sleeve gastrectomy, with focus on H. pylori-related gastritis. The aim was to demonstrate any influence on chronic gastritis of the surgical procedure or its post-operative course.MethodsOne hundred six morbidly obese patients were subjected to vertical sleeve gastrectomy in King Abdulaziz University Hospital (KAUH) from March 2014 to April 2015. After full pre-operative preparation, sleeve gastrectomy was carried out, followed by histological examination of the specimen to view the chronic gastritis and H. pylori-related cases. All epidemiological data of the patients, including age, gender, body mass index (BMI), as well as mean operative time, length of hospital stay, and post-operative complications were documented and analyzed by IBM-SPSS version 22.ResultsFemale patients presented the higher prevalence, i.e., 66% among the group of patients with sleeve resection, while 33% had chronic gastritis and 8.5% had H. pylori-related gastritis.ConclusionThis study highlights the high prevalence of chronic gastritis in morbidly obese patients with reference to the high incidence of H. pylori-related gastritis among them, however no relationship was found between this infection and the post-operative outcome.

show abstract

Two Important Criteria for Reducing the Risk of Postoperative Ulcers at the Gastrojejunostomy Site after Gastric Bypass: Patient Compliance and Type of Gastric Bypass

Cited by 14 publications

References 17 publications

Substance use after bariatric surgery: A review

Substance use after bariatric surgery: A review

ASMBS pediatric metabolic and bariatric surgery guidelines, 2018

Chronic Gastritis in Morbidly Obese Patients with Sleeve Gastrectomy

Contact Info

Product

Resources

About